Zimmer Biomet Holdings (ZBH) is presenting at
Wells Fargo 2024 and
Morgan Stanley Annual Global Healthcare Conferences. Investment firms such as
Raymond James & Associates and
Assenagon Asset Management S.A. have increased their positions, suggesting strong market interest. However, the stock has seen a
decline of 11% this year, according to Jim Cramer. The company's
Q1 and Q2 2024 earnings surpassed expectations, further buoyed by strong earnings and robust business strength. The company recently inked a definitive deal to acquire
OrthoGrid Systems Inc and entered a distribution agreement with
THINK Surgical for the total knee arthroplasty system. Zimmer Biomet also showcased its innovations at the
AAOS 2024 Annual Meeting and enhanced liquidity with new credit facilities. Regulatory approval for the
ROSA® Shoulder System, the world's first robotic assistant for shoulder replacement surgery, was granted. Also,
New York State Teachers Retirement System and
Gradient Investments LLC have multi-million-dollar stakes. The firm announced a strategic plan for future growth and projected an upbeat 2024 profit, though it cut its revenue growth outlook. Incorporation into the portfolio of the TMINI robotic system, a $2 billion stock buyback, and executive leadership changes were other highlights.
Zimmer Biomet Holdings ZBH News Analytics from Tue, 05 Sep 2023 07:00:00 GMT to Sun, 25 Aug 2024 09:35:43 GMT -
Rating 5
- Information 8
- Rumor -2
